Rare Disease Day 2025 is almost here and everyone at Micregen stand in solidarity with the 300 million people, their families & Carers globally affected by rare and life-threatening conditions.
These include Necrotising Enterocolitis (NEC) and Bronchopulmonary Dysplasia (BPD), devastating diseases that primarily impact preterm infants, often with severe and long-term consequences.
Micregen’s cutting-edge, stem cell-derived, cell-free Secretomix® platform is pioneering new approaches to tackle these critical challenges. Our mission is to develop transformative therapies that offer hope to the most vulnerable patients and their families.
On this important day, Micregen wants to support awareness of those impacted by rare diseases and continue our dedication to advancing innovative solutions that can make a real difference.
#RareDiseaseDay #NEC #BPD #PretermInfants #Micregen #StemCellInnovation #Secretomix #HopeForRareDiseases